Terns Pharmaceuticals, Inc. — Director's Dealing 2023

Feb 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2023-02-01

Reporting Person: Quirk Erin (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-01	Stock Option (Right to Buy)	$8.94	A	600000.00	Acquired	2033-01-31	Common Stock (600000.00)	Direct

Footnotes

F1: 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.